IV. Esquemas frasémicos de la categoría HAVE-NEOPLASM y TUMOR

• EVENT_relation_OBJECT
  • HAVE-NEOPLASM_location (event-state-relation: case-role)_BODY-PART
    • HAVE-NEOPLASM_location (event-state-relation: case-role)_PHYSIOLOGICAL-SYSTEM
    • HAVE-NEOPLASM_location (event-state-relation: case-role)_TISSUE
    • HAVE-NEOPLASM_location (event-state-relation: case-role)_CELL
  • HAVE-NEOPLASM_affects-body-part (disease-event-object-relation)_BODY-PART
  • HAVE-NEOPLASM_experiencer (event-state-relation: case-role)_PATIENT
  • HAVE-NEOPLASM_treated-with-the-use-of (disease-event-object-relation)_DRUG
  • HAVE-NEOPLASM_metastatizes-to (disease-event-object-relation)_BODY-PART
  • HAVE-NEOPLASM_origin (event-object-relation)_BODY-PART
• EVENT_relation_EVENT
  • HAVE-NEOPLASM_caused-by (event-state-relation: condition-of-change)_DISEASE-EVENT
  • HAVE-NEOPLASM_diagnosed-with (disease-event-relation)_DIAGNOSTIC-TEST
  • HAVE-NEOPLASM_treated-with (disease-event-relation)_TREATMENT
    • HAVE-NEOPLASM_treated-with (disease-event-relation)_CHEMOTHERAPY
    • HAVE-NEOPLASM_treated-with (disease-event-relation)_SURGICAL-PROCEDURE
    • HAVE-NEOPLASM_treated-with (disease-event-relation)_RADIOTHERAPY
    • HAVE-NEOPLASM_treated-with (disease-event-relation)_ADJUVANT-THERAPY
  • HAVE-NEOPLASM_theme-of (inverse-event-state-relation: inverse-case-role)_MEDICAL-SERVE
  • HAVE-NEOPLASM_theme-of (inverse-event-state-relation: inverse-case-role)_PHYSICAL-EVENT
  • HAVE-NEOPLASM_has-symptom (disease-event-relation)_DISEASE-EVENT
  • HAVE-NEOPLASM_has-risk-factor (disease-event-relation)_LIVING-EVENT
  • HAVE-NEOPLASM_has-prognostic-factor_(disease-event-relation)_LIVING-EVENT
  • HAVE-NEOPLASM_responds-to (disease-event-relation)_TREATMENT
• EVENT_ATTRIBUTE
  • HAVE-NEOPLASM_tumor-condition (literal-disease-event-attribute): benign/borderline/malignant
  • HAVE-NEOPLASM_invasive-attirbue (literal-disease-event-attribute): preinvasive/invasive/non-invasive
  • HAVE-NEOPLASM_tumor-site-attirbute (literal-disease-event-attribute): primary/secondary/residual
  • HAVE-NEOPLASM_primary-site-attribute (binary-disease-event-attribute): known/unknown
  • HAVE-NEOPLASM_primary-tumor-number (literal-disease-event-attribute): first/second
  • HAVE-NEOPLASM_affected-population-age (literal-disease-event-attribute): adult/child
  • HAVE-NEOPLASM_affected-population-age-sex (literal-disease-event-attribute): male/female
  • HAVE-NEOPLASM_diagnosis (literal-disease-event-attribute): name of disease
  • HAVE-NEOPLASM_prognosis-attribute (literal-disease-event-attribute): poor/medium/favorable
  • HAVE-NEOPLASM_treatement-attribute (binary-disease-event-attribute): treated/untreated
  • HAVE-NEOPLASM_metastatic-attribute (binary-disease-event-attribute): metastatic/non-metastatic
  • HAVE-NEOPLASM_risk-factors-evaluation (binary-disease-event-attribute): good/bad
  • HAVE-NEOPLASM_prognostic-factors-evaluation (literal-disease-event-attribute): poor/medium/favourable
  • HAVE-NEOPLASM_clinical-manifestations (binary-disease-event-attribute): symptomatic/asymptomatic
  • HAVE-NEOPLASM_time-science (binary-event-attribute): synchronous/metachronous
  • HAVE-NEOPLASM_genetic-susceptibility (binary-disease-event-attribute): familial / sporadic
  • HAVE-NEOPLASM_laterality (literal-disease-event-attribute): unilateral/bilateral/trilateral
  • HAVE-NEOPLASM_mortality-rate (scalar-disease-event-attribute): %
  • HAVE-NEOPLASM_mortality-rate (literal-disease-event-attribute): low/high
  • HAVE-NEOPLASM_disease-survival (literal-disease-event-attribute): disease-free/overall
  • HAVE-NEOPLASM_survival-duration (scalar-disease-event-attribute): number of years
  • HAVE-NEOPLASM_survival-rate (scalar-disease-event-attribute): %
  • HAVE-NEOPLASM_survival-rate (literal-disease-event-attribute): low/ high
  • HAVE-NEOPLASM_risk-rate (scalar-event-attribute): %
  • HAVE-NEOPLASM_risk-rate (literal-event-attribute): high/low
  • HAVE-NEOPLASM_frequency-rate (scalar-disease-event-attribute): %
  • HAVE-NEOPLASM_frequency-rate (literal-disease-event-attribute): high/ low
  • HAVE-NEOPLASM_risk-potential (literal-disease-event-attribute): high/intermediate/low
  • HAVE-NEOPLASM_progression-attribute (binary-disease-event-attribute): stable/progressive
  • HAVE-NEOPLASM_progress-rate (literal-disease-event-attribute): slow/rapid
  • HAVE-NEOPLASM_responsiveness (literal-disease-event-attribute): complete response/ partial response/ no response
  • HAVE-NEOPLASM_response-sequence (literal-disease-event-attribute): first/second
  • HAVE-NEOPLASM_response-time (literal-disease-event-attribute): slow/rapid
  • HAVE-NEOPLASM_response-duration (literal-disease-event-attribute): transient/durable
  • HAVE-NEOPLASM_response-duration (scalar-disease-event-attribute): number of months/ years
  • HAVE-NEOPLASM_response-rate (scalar-disease-event-attribute): %
  • HAVE-NEOPLASM_response-rate (literal-disease-event-attribute): high/low
  • HAVE-NEOPLASM_curability (binary-disease-event-attribute): curable/incurable
  • HAVE-NEOPLASM_curability-rate (scalar-disease-event-attribute): %
  • HAVE-NEOPLASM_curability-rate (literal-disease-event-attribute): high/medium/low
  • HAVE-NEOPLASM_cancer-staging
    • HAVE-NEOPLASM_TNM-classification (literal-disease-event-attribute): T (X,0,IS,1,1A,1B,1C,2,2A,2B,2C,3, 3A,3B,3CY,4,4A,4B,4C,4D) N (X,0,1,2,3) M (X,0,1)
    • HAVE-NEOPLASM_stage-classification (literal-disease-event-attribute): early/advanced, 0/I (A,B)/II (A,B)/III (A,B)/IV (A,B,S)/V, A/B1/B2/B3/C1/C2/C3, A/A1/A2/B/C/D/D1/D2, chronic phase/accelerated phase/blastic phase
    • HAVE-NEOPLASM_extent-classification (literal-disease-event-attribute): localized/non-localized
    • HAVE-NEOPLASM_invasiveness-classification (literal-disese-event-attribute): deep/superficial
• OBJECT_ATTRIBUTE
  • TUMOR_size (scalar-physical-object-attribute): > 0
  • TUMOR_size (literal-physical-object-attribute): small / medium/large
  • TUMOR_amount (binary-tumor-attribute): single/multiple
  • TUMOR_palpability-attribute (binary-tumor-attribute): palpable/non-palpable
  • TUMOR_tumor-consistency (literal-tumor-attribute): solid/serous
  • TUMOR_resectability (binary-tumor-attribute): resectable/non-resectable
  • TUMOR_secretion (binary-tumor-attribute): secreting/non-secreting
  • TUMOR_histological-composition (literal-tumor-attribute): mixed/pure
  • TUMOR_histology-evaluation (binary-tumor-attribute): favorable/unfavorable
  • TUMOR_tumor-garding
    • TUMOR_tumor-degree-of-differentiation (literal-tumor-attribute): well differentiated/moderately differentiated/poorly differentiated/undifferentiated
    • TUMOR_histologic-tumor-grade (scalar-tumor-attribute): I/II/III/IV
    • TUMOR_histologic-tumor-grade (literal-tumor-attribute): high/medium/low
    • TUMOR_malignancy-potential (literal-tumor-attribute): low/borderline/high

Índice general I Índice Apéndices  I Siguiente